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The fast pace of technological improvement and the rapid development and adoption of healthcare applications
present crucial challenges for clinicians, users and policy makers. Some of the most pressing dilemmas include the
need to ensure the safety of applications and establish their cost-effectiveness while engaging patients and users to
optimize their integration into health decision-making. Healthcare organizations need to consider the risk of
fragmenting clinical practice within the organization as a result of too many apps being developed or used, as well
as mechanisms for app integration into the wider electronic health records through development of governance
framework for their use. The impact of app use on the interactions between clinicians and patients needs to be
explored, together with the skills required for both groups to benefit from the use of apps. Although healthcare
and academic institutions should support the improvements offered by technological advances, they must strive to
do so within robust governance frameworks, after sound evaluation of clinical outcomes and examination of
potential unintended consequences.
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The use of smartphone and tablet applications (apps)
within healthcare is rapidly expanding [1-6] and now
appears socially and professionally acceptable [7]. The
Food and Drug Administration has recently published
guidelines defining the group of apps to which it intends
to apply its authority [8], but whether US legislation
should follow continues to be fiercely debated [9,10].
The European Commission has also issued legislation
regulating the development and use of medical devices,
which covers software utilized in healthcare apps [11].
Many view these steps as a positive move towards rec-
ognition of the role of apps in healthcare as decision
support tools; others, however, may see this additional
governance as cumbersome and a hindrance to effec-
tive use of this rapidly evolving and changing techno-
logy. In the context of the clinical quality improvement
agenda, the question is whether the use of apps needs
to be considered in the same light as other healthcareUK
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post-implementation evaluation and economic assessment.
This is of particular importance for apps designed to
have a direct impact on clinical decision-making, including
medication dose calculation, adjustment of therapy, and for
diagnostic purposes [12,13]. Evidence supports the rapid
adoption of apps for the delivery of healthcare information
and decision support tools to healthcare professionals
[14,15] and patients [16], but studies on the impact of
apps on patient outcomes are lacking.
The unintended consequences of app use in health-
care remain largely unexplored. The inexorable devel-
opment of digital technologies moves at a fast pace and
current devices will be superseded, as suggested by the
advent of wearable devices such as Google Glass and
smartwatches [17]. Likewise, some manufacturers and
standards will disappear, to be replaced by others. It is
pertinent, therefore, to consider the lifespan and sus-
tainability of apps. This is of particular importance
when the funding for developing apps for healthcare or-
ganizations may not only come from private industry
but also from the public sector.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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The lack of seamless access to patient information across
the care pathway remains one of the most pressing issues
in healthcare [18]. The absence of an integrated system
poses a threat to care quality and patient safety as im-
portant clinical decisions have to be made after referring
to multiple electronic systems, raising further issues in
terms of governance and handling of confidential data.
It is possible that the enthusiasm among healthcare pro-
fessionals to use smartphones to help make clinical de-
cisions stems in part from a frustration with existing
information technology systems provided by healthcare
organizations. In this context, apps may have provided a
‘quick fix’ for circumventing the underlying problems
related to healthcare information technology architec-
ture, rather than being horizontally integrated into the
wider health informatics landscape. This in turn is con-
tributing to the observed fragmentation of apps [19].
Apps may provide a robust mechanism for improving
out-of-hours care where one reason for poorer patient
outcomes may be lack of remote access to data to help
inform decision-making by non-resident practitioners.
Utilizing apps to overcome this, however, is mired with
difficulties, chief among them being access to patient data
and patient confidentiality. Existing electronic systems
and servers in healthcare operate behind secure firewalls.
Providing access to patient data through mobile devices
would require careful consideration of the ethical, security
and governance aspects of data handling. But this need
not be a deterrent. If enacted correctly and systematically,
access to patient information through mobile devices can
be much more secure than access through paper records,
which can be transported and/or photocopied and mis-
placed much more easily. Data encryption methods
specifically designed for mHealth apps are now coming
to fruition [18]. However, electronic and digital systems
pose their own threats and resilience to malware and
cyber attacks must be developed [20,21].
One solution to safe access to patient-level data through
mobile devices is for organizations to have clear security
and governance rules in place. These may include the
provision of devices or registering of all mobile devices
used within the organization; registration of individual
users; the use of virtual secure networks; and utilization
of apps designed to prevent data being stored locally on
the device. For those apps that provide patient-level de-
cision support, mechanisms to maintain a decision-
making audit trail must be developed. This may entail
digital logs or print-out-and-sign signatures of health-
care professionals that should be retrievable and
shareable amongst the various apps and electronic and
paper systems used to document the care provided for
individual patients. Furthermore, such systems may
also facilitate sharing of information across patientpathways to support an integrated care approach across
primary and secondary care.
Will increased governance stifle innovation?
The way that healthcare professionals learn and practice
is rapidly changing with technological evolution [22], with
a resulting increased demand for technology among the
workforce [1,2,14,15]. Technological advances cost money
and require additional expertise for successful adoption
and implementation. It is important to assess existing
information technology capabilities within healthcare
organizations and their ability to deliver products to
meet demand. The digital skill of healthcare professionals is
always ahead of the technology that healthcare organiza-
tions adopt. While most healthcare professionals are now
adept at using smartphones and tablets, they continue to
work in healthcare systems that are struggling to renovate
their technologies. We are still some way away from the
goal of working in a paperless system in healthcare and the
opportunity cost of investing in smartphone technology
and apps, especially in light of the need for governance,
may act as a deterrent. Where healthcare information tech-
nology systems are designed with decision support architec-
ture in place (such as electronic prescribing), any additional
benefit offered by apps from their point-of-care nature
should be weighed against incremental costs. To this end,
the Food and Drug Administration has classified applica-
tions used in healthcare into those that provide medical
and scientific information to supplement expertise such as
policy and guidance [14], and those that have diagnostic
and intervention potential [8], a decision that has been wel-
comed. This way the need for legislation and governance
can be targeted to certain applications without stifling the
use of such technology in healthcare altogether.
Healthcare professionals are not the sole users of mo-
bile technology, as patients and service users also have
access to the same tools and potentially to the same
apps. Patients need to be at the center of the techno-
logical advances in healthcare, and scaling up of techno-
logical innovations must include this perspective and
consider supporting patient choice of innovation. The
impact of healthcare apps upon patient participation
and their perception of the clinical experience should
not be underestimated [23]. Additionally, there may be
other unintended consequences, including changes to
patient health-seeking behaviors as a result of access to
information through apps.
Summary
The inevitable future for healthcare is one where electronic
and mobile systems play pivotal roles in healthcare delivery.
From electronic prescribing systems to dispensing robots
and robotic surgery, mobile health solutions are only the
latest in a long line of technological innovations. Healthcare
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nology and not stifle technological progress, but the drive
for development of apps needs to be supported by robust
governance frameworks, and evaluation of the clinical out-
comes and potential unintended consequences. A classifica-
tion system for healthcare applications should be developed
that recognizes and delineates the difference between apps
that support decision-making, and those which purport to
intervene in clinical decisions.
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